Apr 29, 2021
“We see 84% of moms in the U S convert to infant formula partially or entirely in that first six months of life before the recommended period of exclusive breastfeeding ends. We see two thirds of moms express extreme shame and guilt and stigma for the way they feed their children. And, we continue to see that the infant formula industry in general has really pillaged and plundered in a lot of ways on parents wanting to do what's best for their child, but really not having better options and having very little innovation to really think about how to better nourish a child.” Michelle Egger
Michelle Egger is a food scientist and the CEO and co-founder of BIOMILQ, a woman-owned, science-led, mother-centered startup that is creating human breast milk in a lab, by culturing mammary cells. This has the potential for disrupting the infant formula industry forever; and will give families a more nutritious option for feeding their babies.
Michelle founded BIOMILQ with cell biologist Lelia Strickland in January 2020, and soon after they received $3.5 million in funding from Breakthrough Energy Ventures, Bill Gates' investment firm.
I’m beyond excited that BIOMILQ exists. They are creating a revolutionary product that will one day be on grocery store shelves across the world. It will be a game changer for mothers who struggle with breastfeeding, for the planet and for a whole lot of cows.